PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
[31]   THE SIMULTANEOUS DETERMINATION OF ARA-U AND ARA-C, URINARY METABOLITES OF N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE BY MASS FRAGMENTOGRAPHY [J].
MAKINO, Y ;
MATSUBARA, Y ;
WATANABE, K ;
HIROBE, M .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1982, 102 (01) :49-55
[32]   CELLULAR PHARMACOLOGY OF A LIPOSOMAL PREPARATION OF N-4-HEXADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, A LIPOPHILIC DERIVATIVE OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE [J].
HORBER, DH ;
SCHOTT, H ;
SCHWENDENER, RA .
BRITISH JOURNAL OF CANCER, 1995, 71 (05) :957-962
[33]   INCORPORATION OF N-4-BEHENOLY-1-BETA-D-ARABINOFURANOSYLCYTOSINE (BHAC) INTO DNA AS 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) [J].
HIGASHIGAWA, M ;
OHKUBO, T ;
KAWASAKI, H ;
KAMIYA, H ;
SAKURAI, M .
PEDIATRIC RESEARCH, 1988, 24 (01) :120-120
[34]   TREATMENT OF LEUKEMIA AND MYELODYSPLASTIC SYNDROMES WITH ORALLY-ADMINISTERED N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE [J].
OHNO, R ;
HIRANO, M ;
YAMAGATA, K ;
OHARA, K ;
SHIRAKAWA, S ;
HIROTA, Y ;
KOBAYASHI, M ;
YOSHIKAWA, S ;
MITOMO, Y ;
IKEDA, Y ;
MIWA, Y ;
OGURI, T ;
MIZUNO, H ;
YAMADA, H ;
YAMADA, K ;
KIMURA, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) :161-164
[35]   COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA [J].
TIDEFELT, U ;
SUNDMANENGBERG, B ;
PAUL, C .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (04) :225-229
[36]   COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DAUNORUBICIN AND IDARUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA [J].
TIDEFELT, U ;
SUNDMANENGBERG, B ;
PAUL, C .
LEUKEMIA RESEARCH, 1994, 18 (04) :293-297
[37]   A PILOT-STUDY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR ACUTE-LEUKEMIA AND REFRACTORY LYMPHOMA - CLINICAL-RESPONSE AND PHARMACOLOGY [J].
EARLY, AP ;
PREISLER, HD ;
SLOCUM, H ;
RUSTUM, YM .
CANCER RESEARCH, 1982, 42 (04) :1587-1594
[38]   RELATIONSHIP BETWEEN INVITRO PARAMETERS OF CELLULAR 1-BETA-D-ARABINOFURANOSYLCYTOSINE TRIPHOSPHATE (ARACTP) PHARMACOKINETICS AND REMISSION DURATION OF PATIENTS (PTS) WITH ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) [J].
GRECO, WR ;
AZARNIA, N ;
PRIORE, RL ;
PREISLER, HD ;
RUSTUM, YM .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 :195-195
[39]   ACUTE-LEUKEMIA IN PATIENTS WITH A MYELOMA - 4 CASES [J].
BOSSET, JF ;
ROZENBAUM, A ;
FLESCH, M ;
LECONTEDESFLORIS, R ;
LENYS, R .
NOUVELLE PRESSE MEDICALE, 1979, 8 (43) :3562-3562
[40]   CLINICAL-PHARMACOLOGY OF N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES [J].
UEDA, T ;
NAKAMURA, T ;
KAGAWA, D ;
UCHIDA, M ;
DOMAE, N ;
SUGIYAMA, M ;
UEDA, Y ;
SASADA, M ;
UCHINO, H .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (06) :371-375
12345